ArticleChemical science2025
Ultrahigh photocatalytic hydrogen evolution of linear conjugated terpolymers enabled by an ultra-low ratio of the benzothiadiazole monomer.
Article in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Direct arylation polymerization of electron-rich arenes with polar-group tolerance enabled by ligand-coordination tuning.Chemical science · 2026Article
- Facile Access to IDT-Based Acceptor via Direct C-H Arylation and Its Exploration in Binary and Ternary Organic Solar Cells.Chemistry, an Asian journal · 2026Article
- DMolecules (Basel, Switzerland) · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Conjugated terpolymers bearing three kinds of π-monomers have been regarded as a promising platform for photocatalytic hydrogen production (PHP). However, the high-performance terpolymers reported so far typically involve large portions (≥20 mol%) of the third monomer. Efficiently modulating the terpolymer by utilizing minimum content of the third component remains a critical challenge. Herein, we report a donor-acceptor linear terpolymer prepared by atom-economical C-H/C-Br coupling with an ultra-low ratio (0.5 mol%) of benzothiadiazole (BT) as the third monomer, which can efficiently modulate properties and afford a hydrogen evolution rate of up to 222.28 mmol h
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.